bifonazole

⇄

surface glycoprotein ; Severe acute respiratory syndrome coronavirus 2







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35526097 Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen. 2022 May 6 2